onforb.es/11pwse9
http://www.forbes.com/sites/peterlipson/2013/04/19/a-film-producer-a-cancer-doctor-and-their-critics
Didymus Judas Thomas, Contributor
Musings on the intersection of Articles, Bias, and Censorship
(The Big 3: A.B.C.)
4/19/2013 @ 9:43PM
A Film Producer, A Cancer Doctor, And Their Critics
guychapman 5 days ago
“All we can tell from the records is that he completed *one* phase 2 trial (out of 60), with no indication of success or failure, and has not published the full results from a single one of these trials.”
Mr. guychapman (also known as Guy Chapman, @SceptiGuy, @vGuyUK), when does this say he must publish human clinical trials by?
Burzynski: Declaration of Helsinki:
https://stanislawrajmundburzynski.wordpress.com/2013/04/25/burzynski-declaration-of-helsinki
“Here’s a really simple question for you: what is Burzynski’s median five-year survival rate compared with standard of care for specific tumour types and stages?”
Mr. guychapman, have you looked here?
Burzynski Clinical Trials (The SEC filings)
https://stanislawrajmundburzynski.wordpress.com/2013/04/11/burzynski-clinical-trials-2
“You’ll need to cite a reliable independent source, of course.”
Mr. guychapman, have you looked here?
Burzynski: What happens when a clinical trial is over?
https://stanislawrajmundburzynski.wordpress.com/2013/04/25/burzynski-what-happens-when-a-clinical-trial-is-over
“You know, a peer-reviewed publication of decent quality.”
Mr. guychapman, have you looked here?
The “National Cancer Institute (NCI) at the National Institutes of Health (NIH)
Cancer Clinical Trials
15. What happens when a clinical trial is over?
http://m.cancer.gov/topics/factsheets/clinical-trials
advises:
“The results of clinical trials are OFTEN published in peer-reviewed scientific journals”
” … WHETHER OR NOT the results are published in a peer-reviewed scientific journal … “
This makes it clear that clinical trial results “are OFTEN” published, but sometimes they are “NOT” published “in a peer-reviewed scientific journal”
“He claims to have treated thousands of patients, this cohort is large enough to perform at least some basic statistical analysis.”
Mr. guychapman, have you looked here?
Burzynski – The Antineoplaston Randomized Japan Phase II Clinical Trial Study
https://stanislawrajmundburzynski.wordpress.com/2013/03/28/burzynski-the-antineoplaston-randomized-japan-phase-ii-clinical-trial-study
JGC2013 4 days ago
“Actually, although Burzynski did submit a design for a phase III trial round about 2009, as of this date not a single patient has been enrolled in this study.”
JGC2013, did you read the Securities and Exchange Commission (SEC) filings?
Burzynski’s Securities and Exchange Commission (SEC) Form 10-Q for the quarterly period ended 5/31/2010 states:
1/13/2009 Company announced Company had reached an agreement with FDA for Company to move forward with pivotal Phase III clinical trial of combination Antineoplaston therapy plus radiation therapy in patients with newly diagnosed, diffuse, intrinsic brainstem gliomas (DBSG)
Agreement was made under FDA’s Special Protocol Assessment procedure, meaning design and planned analysis of Phase III study is acceptable to support regulatory submission seeking new drug approval
2/1/2010 Company entered into agreement with Cycle Solutions, Inc., dba ResearchPoint to initiate and manage pivotal Phase III clinical trial of combination Antineoplastons A10 and AS2-1 plus radiation therapy (RT) in patients with newly-diagnosed, diffuse, intrinsic brainstem glioma
ResearchPoint is currently conducting feasibility assessment
ResearchPoint has secured interest and commitment from number of sites selected
Upon completion of assessment, randomized, international phase III study will commence
Study’s objective is to compare overall survival of children with newly-diagnosed DBSG who receive combination Antineoplastons A10 and AS2-1 plus RT versus RT alone
JGC2013, but then again:
Burzynski: Not every cancer clinical trial taking place in the United States is listed on our NCI clinical trials database
https://stanislawrajmundburzynski.wordpress.com/2013/04/26/burzynski-not-every-cancer-clinical-trial-taking-place-in-the-united-states-is-listed-on-our-nci-clinical-trials-database
FW 6 days ago
“And yet the American Cancer Society makes exactly the same criticisms of Burzynki that all other critics do:”
http://www.cancer.org/treatment/treatmentsandsideeffects/complementaryandalternativemedicine/pharmacologicalandbiologicaltreatment/antineoplaston-therapy
“No credible evidence.”
FW (also known as @frozenwarning), where is their independent antineoplaston clinical study publications?
rjblaskiewicz 6 days ago
“It’s not a thread about the inherent corruption throughout all of medicine.”
“It’s about some bully/man-child trying to shut up critics.”
Mr. rjblaskiewicz (also known as Bob Blaskiewicz, so, like Forbes was?
A Film Producer, A Cancer Doctor, And Their Critics:
https://stanislawrajmundburzynski.wordpress.com/2013/04/20/a-film-producer-a-cancer-doctor-and-their-critics
Forbes censors Peter Lipson “Speech is best countered by more speech” article comments:
https://stanislawrajmundburzynski.wordpress.com/2013/04/23/forbes-censors-peter-lipson-speech-is-best-countered-by-more-speech-article-comments
Dr. Peter A. Lipson (and / or his Censor(s)) is a Coward: Critiquing “A Film Producer, A Cancer Doctor, And Their Critics:”
https://stanislawrajmundburzynski.wordpress.com/2013/04/26/dr-peter-a-lipson-and-or-his-censors-is-a-coward-critiquing-a-film-producer-a-cancer-doctor-and-their-critics
“You are wrong. But you know this.”
https://stanislawrajmundburzynski.wordpress.com/2013/03/26/critiquing-bob-blaskiewicz-burzynski-cancer-is-serious-business-part-ii
3/26/2013
https://stanislawrajmundburzynski.wordpress.com/2013/03/26/my-critique-of-bob-blaskiewicz-colorado-public-television-pbs-cpt12
Called-out comment
FW 6 days ago
“junkeroo, when you post something rational and intelligible,I will happily respond.”
FW (also known as @frozenwarning), when you post something rational and intelligible, I will happily respond.”
onforb.es/11pwse9
http://www.forbes.com/sites/peterlipson/2013/04/19/a-film-producer-a-cancer-doctor-and-their-critics
“Instead of cherry picking 20 year old newspaper articles, can I suggest that you try and explain why Burzynski has started 60+ trials, finished one, and never reported the results in peer reviewed journals as any reputable scientist should do?”
FW, have you read these?
Burzynski: What happens when a clinical trial is over?
https://stanislawrajmundburzynski.wordpress.com/2013/04/25/burzynski-what-happens-when-a-clinical-trial-is-over
The “National Cancer Institute (NCI) at the National Institutes of Health (NIH)
Cancer Clinical Trials
15. What happens when a clinical trial is over?
http://m.cancer.gov/topics/factsheets/clinical-trials
advises:
“The results of clinical trials are OFTEN published in peer-reviewed scientific journals”
” … WHETHER OR NOT the results are published in a peer-reviewed scientific journal … “
This makes it clear that clinical trial results “are OFTEN” published, but sometimes they are “NOT” published “in a peer-reviewed scientific journal”
"As for this mythical Phase 3 trial, which was registered in 2010 and has yet to recruit a single patient, in a tumour that is relatively curable by real medicine."
"I suspect permission to do this was an attempt by the FDA to force Burzynski to do a decent RCT."
"Unfortunately it backfired, because he seems quite happy to never start this trial, instead using it as a marketing tool, in the same way as he is happy to use individual patients."
FW, why was the FDA requiring “radiation
” in the phase 3 clinical trial?
” … only obstacles now are $300 million $s needed to pay for final phase of clinical testing-and FDA requiring children with inoperable brainstem glioma to also undergo radiation
treatment in Phase 3 trials, claiming it would be “unethical” not to do so”
Boris Ogon
“You are right now having a live “debate” in front of more than 10,000 people, … “
3,791 views</strong
Not so much
Waiting for the 10,000
| 4/19/2013 @ 9:43PM
Peter Lipson: “Speech is best countered by more speech”